These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome. Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300 [TBL] [Abstract][Full Text] [Related]
3. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Srivastava P; Lone TA; Kapoor R; Mittal RD Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248 [TBL] [Abstract][Full Text] [Related]
4. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians. Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195 [TBL] [Abstract][Full Text] [Related]
5. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India. Srivastava P; Kapoor R; Mittal RD Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review. Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481 [TBL] [Abstract][Full Text] [Related]
9. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer]. Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692 [TBL] [Abstract][Full Text] [Related]
10. High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome. Yadav SS; Mandal RK; Singh MK; Verma A; Dwivedi P; Sethi R; Usman K; Khattri S DNA Cell Biol; 2014 Nov; 33(11):816-22. PubMed ID: 25211325 [TBL] [Abstract][Full Text] [Related]
11. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564 [TBL] [Abstract][Full Text] [Related]
12. Association of cluster of differentiation 36 gene variant rs1761667 (G>A) with metabolic syndrome in Egyptian adults. Bayoumy NM; El-Shabrawi MM; Hassan HH Saudi Med J; 2012 May; 33(5):489-94. PubMed ID: 22588808 [TBL] [Abstract][Full Text] [Related]
13. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. O-Charoenrat P; Khantapura P Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157 [TBL] [Abstract][Full Text] [Related]
14. Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study. Hosseini-Esfahani F; Mirmiran P; Daneshpour MS; Mehrabi Y; Hedayati M; Soheilian-Khorzoghi M; Azizi F Br J Nutr; 2015 Feb; 113(4):644-53. PubMed ID: 25653052 [TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population. Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680 [TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721 [TBL] [Abstract][Full Text] [Related]
17. [Association of NLRP3 gene single nucleotide polymorphisms with metabolic syndrome]. Zhang L; Zhang D; Zheng Y; Hu Z; Zeng Y; Yue F Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Aug; 33(4):530-4. PubMed ID: 27455015 [TBL] [Abstract][Full Text] [Related]
18. Let-7 related genetic variation and risk of metabolic syndrome in a Chinese population. Yan YX; Wu LJ; Zhang J; Wang S; Wang W; Dong J; He Y Endocr J; 2015; 62(10):887-96. PubMed ID: 26178671 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related]
20. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]